抗生素浸渍导管用于新生儿及婴儿脑室腹腔分流术的系统评价与荟萃分析
该系统评价与荟萃分析纳入7项研究共1009例新生儿及婴儿,比较使用与不使用抗生素浸渍导管(AIC)行脑室腹腔分流术(VPS)的结局。结果显示AIC与总体分流感染风险显著降低相关(OR 0.27;95%CI 0.15-1.03;P<0.01;I²=0%),婴儿和新生儿亚组均显著获益,革兰阳性球菌感染显著减少,首次感染时间显著延长(均差4.6个月;95%CI 2.2-6.9;P<0.01)。结论推荐常规使用AIC。
要点
- AIC使新生儿及婴儿VPS总体分流感染风险显著降低(OR 0.27)。
- 婴儿和新生儿亚组感染风险均显著下降(OR分别为0.29和0.26)。
- AIC显著减少革兰阳性球菌感染并延长首次感染时间。
核心结论
- AIC可显著降低新生儿及婴儿VPS分流感染风险并延迟感染发生,尤其针对革兰阳性菌,推荐常规使用。
研究设计与样本
- 系统评价与荟萃分析,纳入7项研究共1009例接受VPS的新生儿及婴儿,比较使用与不使用AIC的结局,采用随机效应模型计算合并OR、均差及95%CI。
主要发现
- AIC组总体分流感染风险显著低于标准导管组(OR 0.27;95%CI 0.15-1.03;P<0.01;I²=0%)。
- 婴儿亚组感染风险显著降低(OR 0.29;95%CI 0.12-0.67;P=0.004),新生儿亚组亦显著降低(OR 0.26;95%CI 0.11-0.62;P<0.01)。
- AIC显著减少革兰阳性球菌感染(OR 0.20;95%CI 0.06-0.69;P=0.01),但对革兰阴性杆菌感染无显著影响。
- AIC组首次感染时间显著延长(均差4.6个月;95%CI 2.2-6.9;P<0.01),且6个月及以后感染风险持续较低。
关键数值与推荐
- AIC使用与总体分流感染风险降低相关(OR 0.27;95%CI 0.15-1.03;P<0.01;I²=0%)。
- 婴儿亚组OR 0.29(95%CI 0.12-0.67;P=0.004),新生儿亚组OR 0.26(95%CI 0.11-0.62;P<0.01)。
- 革兰阳性球菌感染OR 0.20(95%CI 0.06-0.69;P=0.01),革兰阴性杆菌感染无显著差异。
- 首次感染时间均差4.6个月(95%CI 2.2-6.9;P<0.01)。
临床怎么用
- 对接受VPS的新生儿及婴儿,可考虑常规使用AIC以降低分流感染风险,尤其针对革兰阳性球菌感染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ventriculoperitoneal shunt (VPS) is the standard treatment for hydrocephalus in neonates and infants, but is commonly complicated by shunt infections. Antibiotic-impregnated catheters (AICs) have been introduced to mitigate infection risk; however, their effectiveness remains uncertain. METHODS: We conducted a systematic review and meta-analysis comparing outcomes in neonates and infants who underwent VPS with and without AICs. Primary outcomes included shunt infection risk, time to first infection, and infections caused by gram-positive cocci and gram-negative rods. Pooled odds ratios (ORs), mean differences, and 95% confidence intervals (CIs) were calculated using random-effects models. RESULTS: Seven studies encompassing 1,009 patients were included. The use of AICs was associated with a significant three-fold reduction in overall shunt infection risk compared to standard catheters (OR 0.27; 95% CI 0.15-1.03; P < 0.01; I² = 0%). Subgroup analysis showed significant infection risk reduction in infants (OR 0.29; 95% CI 0.12-0.67; P = 0.004) and neonates (OR 0.26; 95% CI 0.11-0.62; P < 0.01). AICs led to a significant decrease in gram-positive cocci infections (OR 0.20; 95% CI 0.06-0.69; P = 0.01) but not gram-negative rod infections. The time to first infection was significantly prolonged in the AIC group (mean difference 4.6 months; 95% CI 2.2-6.9; P < 0.01). Lower infection risk persisted at 6 months and beyond. CONCLUSIONS: AICs substantially reduce infection risk and delay infection onset in neonates and infants undergoing VPS, particularly for gram-positive bacteria. Routine use is recommended.
引用
- Fagundes W, Ahmed AR, Silva YP, et al. Antibiotic-Impregnated Catheters for Ventriculoperitoneal Shunt in Neonates and Infants: A Systematic Review and Meta-Analysis. World Neurosurg. 2025. PMID: 40545034. doi:10.1016/j.wneu.2025.124195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。